QX-222

貨號 Cat. No.
Q-200
規格 Size
25 mg 5x25mg

Description

QX-222


A Quarternary Derivative of the Local Anesthetic Lidocaine.











Product#: Q-200

























Sizes:
25 mg
5 x 25 mg
 
 
 
 














M.W.: 261








 










Purity: >98%












Bioassay:
Inhibition of native NaV channels in ND7-23 cells by QX-222 external application.










Inhibitory effect of 10 mM QX-222 on native NaV currents in ND7-23 cells, using the whole cell patch clamp method. Inward currents were elicited from holding potential of -100 mV by a 40 ms test pulse to -10 mV delivered every 10 seconds. Superimposed traces show the response before (black) and during bath application of 10 mM QX-222 (orange).







 









References:


















1.


Gintant G. A. and Hoffman B. F. (1984) Pflugers Arch. 400, 121.

2.


Tsang, S. Y. et al. (2005) Mol. Pharmacol. 67, 424.

3.


Neher E. and  Steinbach J. H. (1978) J. Physiol. 277, 153.


QX-222 is a quarternary derivative of the local anesthetic Lidocaine. It was shown to block NaV currents and channels in a use dependent manner.1 The mechanism of block involves intracellular binding site, but some NaV channels facilitate the passage of QX-222 via the open channel.2 In addition it was shown to inhibit nicotinic ACh receptor channels.3


 


 

詢價 / 洽詢此產品

回到產品列表

▲ LINE
諮詢